Given its pivotal role in DNA repair, MRE11 is a potential target for cancer therapy. By inhibiting MRE11's function, cancer cells, which rely heavily on DNA repair mechanisms due to their high proliferation rate and genomic instability, can be sensitized to DNA-damaging agents like chemotherapy and radiation therapy. Several studies are exploring small molecule inhibitors targeting the MRN complex to enhance the efficacy of existing cancer treatments.
